GlaxoSmithKline Pharmaceuticals P/E Ratio
GLAXO • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
38.56
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
38.56
Current Price
₹2333.40
EPS (TTM)
₹54.76
Exchange
NSE
Valuation Signal
Signal
Overvalued
Historical Avg
40.05
Historical Range
17.35 - 55.72
Percentile
50.0%
Sector Context
Sector Average
47.56
Sector Median
25.5
Sector Rank
#11 of 139
Sector Percentile
7.9%
Earnings Breakdown (TTM)
TTM EPS
₹59.23
Sept 2025
₹15.07
Mar 2025
₹15.52
Key P/E Ratio Insights for GlaxoSmithKline Pharmaceuticals
- Stock appears overvalued with PE of 38.56, suggesting caution for new investments
- Trading at discount to sector average PE of 47.56
P/E Ratio Historical Trend for GlaxoSmithKline Pharmaceuticals
Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.
Related Pages for GlaxoSmithKline Pharmaceuticals
Additional stock information and data for GLAXO
Historical P/E Ratio Data
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 37.69 | 59.23 | ₹2232.10 | NSE | High |
| 2024 | 38.74 | 50.37 | ₹1951.55 | NSE | High |
| 2023 | 35.4 | 37.18 | ₹1316.30 | NSE | High |
| 2022 | 17.35 | 100.13 | ₹1737.15 | NSE | Moderate |
| 2021 | 55.72 | 28.92 | ₹1611.50 | NSE | High |
| 2020 | 55.39 | 29.46 | ₹1631.85 | NSE | High |
Sector P/E Ratio Comparison
Comparing GlaxoSmithKline Pharmaceuticals with other companies in Healthcare sector
Sector Average
47.56
Sector Median
25.5
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.83 | ₹31 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.53 | ₹1,133 | Low |
| Amwill Health Care | AMWILL | 5.67 | ₹64 | Low |
| Brooks Laboratories | BROOKS | 6.14 | ₹157 | Low |
| Medicamen Organics | MEDIORG | 6.4 | ₹27 | Low |
| Zenith Drugs | ZENITHDRUG | 6.83 | ₹69 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.15 | ₹2,100 | Low |
| Galaxy Medicare | GML | 7.41 | ₹26 | Low |
| Vasundhara Rasayans | VRL | 9.35 | ₹34 | Low |